Zobrazeno 21 - 30
of 156
pro vyhledávání: '"Aaron P. Rapoport"'
Publikováno v:
Blood
Introduction: Standard induction therapy for multiple myeloma consists of 3-6 cycles of bortezomib, lenalidomide, and dexamethasone (VRd) or carfilzomib, lenalidomide and dexamethasone (KRd). Receiving greater than 6 cycles of a lenalidomide containi
Autor:
Nancy M. Hardy, Kim G. Hankey, Seung Tae Lee, Aaron P. Rapoport, Mehmet Hakan Kocoglu, Nancy Smith, Tim Luetkens, Patricia Lesho, Sherri Bauman, Djordje Atanackovic, Jean A. Yared, Kathleen Ruehle, John W Baddley, Philip Margiotta, Stephanie Avila, Jennie Y. Law, Saurabh Dahiya
Publikováno v:
Blood
Introduction: Patients with hematologic malignancies are at an increased risk of morbidity and mortality from COVID-19 disease (Vijenthira, Blood 2020). This is likely a result of combination of immunodeficiency conferred by the disease and the thera
Autor:
Aaron P. Rapoport, Sandrine Niyongere
Publikováno v:
Haematologica
We have developed a personalized vaccine whereby patient derived leukemia cells are fused to autologous dendritic cells, evoking a polyclonal T cell response against shared and neo-antigens. We postulated that the dendritic cell (DC)/AML fusion vacci
Autor:
Ali Bukhari, David Gottlieb, Noa G. Holtzman, Forat Lutfi, Jonathan Siglin, Nancy M. Hardy, Pranshu Mohindra, Seung Tae Lee, Santanu Samanta, Aaron P. Rapoport, Dong Kim, Jean Yared, Mehmet Hakan Kocoglu, Moaath Mustafa Ali, Jason K. Molitoris, Saurabh Dahiya, Ankit Kansagra, Jingsheng Yan
Publikováno v:
Transplantation and Cellular Therapy. 27:S195-S196
Introduction:Chimeric antigen receptor T-cell (CAR-T) therapy has become an important treatment modality for patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL). However, many of these patients have aggressive disease and require a f
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathy
Autor:
Saurabh Dahiya, Perry K. Richardson, Khushali Jhaveri, Aaron P. Rapoport, Ilana Schlam, Monica Peravali, Noa G. Holtzman, Vera Malkovska
Publikováno v:
Blood Adv
Key Points CAR T-cell therapy was safe and effective in a DLBCL patient with coexisting autoimmune neuropathy. CD19 CAR T-cell therapy may control refractory autoantibodies and monoclonal gammopathies.
Autor:
Elizabeth Hutnick, Saurabh Dahiya, Moaath Mustafa Ali, Ali Bukhari, Gabriela Sanchez-Petitto, Noa G. Holtzman, Kathleen Ruehle, Natalie Gahres, Jean Yared, Nancy M. Hardy, Aaron P. Rapoport, Forat Lutfi, Seung Tae Lee, David Gottlieb, Mehmet H. Kocoglu, Kim Hankey, Dong Kim, Jonathan Siglin
Publikováno v:
British journal of haematologyReferences. 192(1)
Autor:
Djordje Atanackovic, Ryan A. Metcalf, Patricia R. Slev, Adam M. Spivak, Robert C. Blaylock, Vicente Planelles, Mohammad M. Sajadi, Yue Zheng, Heather D. Mannuel, Erin T. Larragoite, Mary Steinbach, Aaron P. Rapoport, Tim Luetkens, Emily S Spivak, Thomas B. Martins, Kim G. Hankey, Stephanie V. Avila
Publikováno v:
Blood Advances
Key Points A severely immunocompromised patient with MM and COVID19 who received a convalescent plasma product showed SARS-CoV-2 clearance. The convalescent plasma showed humoral immunity against all structural SARS-CoV-2 proteins, which was successf
Autor:
Jay Y. Spiegel, Saurabh Dahiya, Khoan Vu, Miriam T. Jacobs, Abhinav Deol, Kathleen A. Dorritie, N. Nora Bennani, Julie M. Vose, David B. Miklos, Patrick M. Reagan, Matthew A. Lunning, Armin Ghobadi, Aaron P. Rapoport, Frederick L. Locke, Loretta J. Nastoupil, Charalambos Andreadis, John S. Tamaresis, Yi Lin, Michael D. Jain, Brian T. Hill, Joseph P. McGuirk, Olalekan O. Oluwole, Sattva S. Neelapu, Andre Goy, Javier Munoz, Lazaros J. Lekakis
Publikováno v:
Blood
Autor:
Forat Lutfi, Ali Bukhari, Ankit J. Kansagra, Aaron P. Rapoport, Jonathan Siglin, Saurabh Dahiya, Jean A. Yared
Publikováno v:
Critical reviews in oncology/hematology. 152
Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the field of hematologic malignancies and are potentially curative in patients with previously limited options. This review highlights key abstracts focusing on clinical studies in C
Autor:
Saurabh Dahiya, Carl Shanholtz, Aaron P. Rapoport, Noa G. Holtzman, Forat Lutfi, Jonathan Siglin, Jean A. Yared, Ali Bukhari, Nancy M. Hardy
Publikováno v:
Leukemialymphoma. 61(9)
Chimeric antigen receptor T-cell(CAR-T) therapy is an increasingly utilized treatment modality with FDA approval for relapsed or refractory(R/R) CD19 positive B-cell Acute Lymphoblastic Leukemia(B-...